Charles Ascher-Walsh, MD
Gynecology · New York, NYNPI 1780626317
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $32,948 of the $42,593 with a category attached, or 77.4%. Gynesonics, Inc. accounts for 61.3% of it on its own, with 9 other manufacturers making up the rest. Among gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $1092.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gynesonics, Inc.$26K
- Provepharm Inc.$9K
- Caldera Medical, Inc$7K
- Femselect Inc.$464
- Coloplast$144
- Medtronic$51
- plus $135 from 4 others
What the payments were for
- Consulting fees$32,94877%
- Travel & lodging$7,11617%
- Food & beverage$2,4796%
- Gifts$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gynesonics, Inc. | 20 | $26,102 |
| Provepharm Inc. | 3 | $8,767 |
| Caldera Medical, Inc | 5 | $6,929 |
| Femselect Inc. | 2 | $464 |
| Coloplast | 2 | $144 |
| Medtronic(2 entities) | 2 | $51 |
| AbbVie | 2 | $41 |
| Boston Scientific | 1 | $41 |
| Hologic Sales And Service, LLC | 1 | $34 |
| Urocure LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$25,970
- BLUDIGO$8,767
- Desara$6,818
- EnPlace$464
How this compares
$42,593 in reported general payments places this provider in the 95th percentile of 240 gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 23 | $10,725 |
| Estradiol | 115 | $7,951 |
| PremarinEstrogens, Conjugated | 13 | $5,733 |
| YuvafemEstradiol | 11 | $799 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 28 | $213 |
Paid to pharmacies, not to this prescriber.
Other gynecology in New York
- Arnold AdvinculaNew York$2.1M
- Tamara KolevNew York$91K
- Paula CastanoNew York$31K
- Christopher EswarNew York$25K
- Neena AgarwalaNew York$17K
- Tara AllmenNew York$8K
- Jorge VenegasNew York$7K
- Molly McBrideNew York$7K
- Connie LiuNew York$7K
- Owen DavisNew York$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.